Bliss JM, Tovey H, Evans A, Holcombe C, et al. Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015). Breast Cancer Res 2023;25:39.
PMID: 37046348